Clinical Trials on Coronavirus Infection in 2019 (COVID-19) in Switzerland

Total 89 results

Hôpital du Valais

Recruiting

Prognostic of Dysfunctional Breathing in Long Covid: a Follow up Study

COVID-19 | Dysfunctional Breathing

Switzerland
University of Social Sciences and Humanities, Warsaw

Completed

Health Behavior Change During COVID-19 Pandemic

Health Behavior

China, Italy, Switzerland, Israel, Germany, France, Australia, Canada, Gambia, Malaysia, Poland, Portugal, Romania, Singapore
Hoffmann-La Roche
Atea Pharmaceuticals, Inc.

Terminated

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study (MEADOWSPRING)

COVID-19 | Long COVID

Denmark, Switzerland, Turkey, Belgium, Mexico, Brazil, Argentina, Germany, Romania, Ukraine
University Hospital, Basel, Switzerland

Completed

Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine (MACIS)

Myocarditis

Switzerland
University of Zurich

Active, not recruiting

The RIsk Stratification in COVID-19 Patients in the ICU Registry (RISC-19-ICU)

COVID-19 | Critical Illness | Inflammatory Response | ARDS | Circulatory Shock

Switzerland
University of Zurich
Cantonal Hospital of St. Gallen; Triemli Hospital; Kantonsspital Münsterlingen

Completed

Sevoflurane in COVID-19 ARDS (SevCov)

Coronavirus | ARDS, Human

Switzerland
Kinarus AG

Suspended

The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2 (KIN-FAST)

COVID-19

Switzerland, Germany
University of Zurich
Wroclaw Medical University

Unknown

The Global PCHF-COVICAV Registry (PCHF-COVICAV)

Cardiovascular Diseases | Heart Failure | COVID-19 | Cardiovascular Risk Factor

Switzerland
University Hospital, Basel, Switzerland
Novartis; Swiss National Science Foundation

Completed

Canakinumab in Patients With COVID-19 and Type 2 Diabetes (CanCovDia)

Coronavirus Infection | Diabetes Mellitus, Type 2

Switzerland
Naser Morina
The University of New South Wales

Unknown

RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19

Depression | Covid19 | Stress | Burnout | Anxiety

Switzerland
ANRS, Emerging Infectious Diseases
University Hospital, Geneva

Recruiting

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial (OPTICOV)

COVID-19 | Immunodeficiency

Switzerland, France
Simon Annaheim
Kliniken Valens, Klinik Gais

Recruiting

Disease-related Fatigue Monitoring Based on Body Signals Measured on the Skin (Fatignals)

Post-COVID-19 Related Fatigue

Switzerland
Jeremia Held

Completed

Stroke Rehabilitation Outcome During COVID-19 Lockdown (SROCL)

Stroke | COVID-19 | Rehabilitation | Cohort Studies

Switzerland
University Hospital, Geneva
University Hospital, Basel, Switzerland; Hôpital Fribourgeois; Ospedale Regionale...

Recruiting

Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19

Covid19 | Old Age; Debility | Immuno-Deficiency

Switzerland
Insel Gruppe AG, University Hospital Bern

Terminated

Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19

COVID | Corona Virus Infection | Sars-CoV2

Switzerland
University of Zurich

Enrolling by invitation

Long-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness Survivors (LUNGTERMcov)

Critical Illness | Covid19 | ARDS | Neurocognitive Dysfunction

Switzerland
Salah D. Qanadli
University of Zurich; University of Bern; University of Basel; University of Geneva...

Active, not recruiting

Vascular Abnormalities Detected With Chest CT in COVID-19 (COVID-CAVA)

Pneumonia, Viral | Covid19 | Pulmonary Embolism

Switzerland
Insel Gruppe AG, University Hospital Bern
Cystic Fibrosis Foundation; European Cystic Fibrosis Society

Recruiting

COVID-19 Antibody Responses In Cystic Fibrosis (CAR-CF)

Cystic Fibrosis

Switzerland
University Hospital Inselspital, Berne

Completed

Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19

COVID-19

Switzerland
Centre Hospitalier Universitaire Vaudois
Larissa University Hospital; Hospital de Egas Moniz; Society of Vascular and...

Recruiting

Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19

Covid19 | Ischemic Stroke

Switzerland
University of Lausanne Hospitals

Completed

Physiological Response to Prone Position in COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)

ARDS | Sars-CoV-2 Infection

Switzerland
University Children's Hospital Basel

Completed

Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)

Paediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS)

Switzerland
Association pour la Complementarite des Connaissances...
AstraZeneca; Menarini Group; Hylab, Grenoble

Completed

Responses to CPET in Subjects With Persistent Exercise Intolerance After COVID-19: an Open-Source Exercise Network

COVID-19

France, Canada, Martinique, Switzerland
National Institute of Allergy and Infectious Diseases...
National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaborators

Completed

Vaccination for Recovered Inpatients With COVID-19 (VATICO)

Covid19

United States, Spain, Uganda, Nigeria, Singapore, Switzerland
Scandinavian Critical Care Trials Group
Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaborators

Completed

Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia (COVIDSTEROID2)

Hypoxia | Covid19

Sweden, India, Denmark, Switzerland
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Active, not recruiting

COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program (COVISQAR)

Chronic Thromboembolic Pulmonary Hypertension | Myopathy | Restrictive Lung Disease | Covid19 Pneumonia

Switzerland
Olatec Therapeutics LLC
CTI Clinical Trial and Consulting Services

Terminated

Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome

Covid19 | Cytokine Release Syndrome

United States, Switzerland
Gilead Sciences

Approved for marketing

Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)

SARS-CoV2 Infection

United States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
University of Zurich

Recruiting

Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress Syndrome (LungMechCoV-19)

Covid19 | ARDS

Switzerland
University of Zurich
University Hospital, Geneva; University Hospital Inselspital, Berne; University... and other collaborators

Terminated

Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19

COVID-19 | Pulmonary Embolism, Deep Vein Thrombosis

Switzerland, Germany
Hoffmann-La Roche
Atea Pharmaceuticals, Inc.

Terminated

Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19 (MORNINGSKY)

COVID-19

Switzerland, Turkey, Denmark, Belgium, Japan, Mexico, Argentina, Brazil, Germany, Portugal, Romania, Ukraine
National Institute of Allergy and Infectious Diseases...
National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaborators

Completed

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

COVID-19

United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
National Institute of Allergy and Infectious Diseases...
National Heart, Lung, and Blood Institute (NHLBI); AstraZeneca; University of... and other collaborators

Active, not recruiting

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

COVID-19

United States, Denmark, Greece, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
National Institute of Allergy and Infectious Diseases...
National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaborators

Completed

BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

COVID-19

United States, Denmark, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
National Institute of Allergy and Infectious Diseases...
National Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline; University... and other collaborators

Completed

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

COVID-19

United States, Denmark, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
Gilead Sciences

Completed

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment

COVID-19

United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
Gilead Sciences

Completed

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)

COVID-19

United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
National Institute of Allergy and Infectious Diseases...
Eli Lilly and Company; National Heart, Lung, and Blood Institute (NHLBI); Gla... and other collaborators

Completed

ACTIV-3: Therapeutics for Inpatients With COVID-19 (TICO)

Covid19

United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
University Hospital, Clermont-Ferrand
Groupe Hospitalier Pitie-Salpetriere; University Hospital Schleswig-Holstein; Hospital Clínico Universitario de Valencia

Completed

Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19) (ISCA)

Acute Respiratory Distress Syndrome | Sedation | Invasive Mechanical Ventilation | Critically Illness

United States, France, Spain, Germany, Switzerland

Clinical Trials on Coronavirus Infection in 2019 (COVID-19) in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations